Form 4: Tandem Diabetes Care Executive Reports Stock Transactions
SEC Form 4 Filing
Susan Morrison, EVP & Chief Admin. Officer at Tandem Diabetes Care, reports the vesting and tax withholding of restricted stock units.
Summary
- Susan Morrison, an executive at Tandem Diabetes Care, reported several transactions involving the company's stock on November 15, 2024.
- These transactions include the vesting of restricted stock units (RSUs) and the subsequent withholding of shares to cover tax obligations.
- No shares were sold on the open market, the shares were withheld by the company to satisfy tax obligations.
- The transactions involved the vesting of 162, 475, and 1,503 RSUs, which converted into common stock.
- A portion of the vested shares were withheld to cover tax obligations at a price of $27.34 per share.
- After these transactions, Ms. Morrison beneficially owns 24,899 shares of common stock and 9,019 restricted stock units.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and does not indicate any significant positive or negative events. The sentiment is neutral to slightly positive due to the vesting of RSUs.
Positives
- The vesting of RSUs indicates that performance milestones were met.
- The executive's continued holding of a significant number of shares and RSUs aligns her interests with those of the shareholders.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into executive compensation and ownership.
Comparison to Industry Standards
- Stock-based compensation, including RSUs, is a standard practice in the technology and medical device industries, used to align executive interests with company performance.
- The vesting schedules described are typical for RSU grants, with a portion vesting initially and the remainder over a period of time.
- Tax withholding on vesting is a standard procedure to cover income tax obligations.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders as they demonstrate that the executive is incentivized to perform well.
- The transactions have no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/18/2021 | Date of initial RSU award under the 2013 Stock Incentive Plan. |
| 05/15/2022 | First vesting date for the RSU awarded on May 18, 2021. |
| 05/25/2022 | Date of RSU award under the 2013 Stock Incentive Plan. |
| 05/15/2023 | First vesting date for the RSU awarded on May 25, 2022. |
| 05/25/2023 | Date of RSU award under the 2023 Long-Term Incentive Plan. |
| 05/15/2024 | First vesting date for the RSU awarded on May 25, 2023. |
| 11/15/2024 | Date of reported stock transactions. |
| 11/19/2024 | Date of filing the Form 4. |
Keywords
Tandem Diabetes Care, Stock Transactions, Restricted Stock Units, RSU, Executive Compensation, Form 4, Insider Trading, Susan Morrison
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.